Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA).
Esteban I, Pastor-Quiñones C, Usero L, Aurrecoechea E, Franceschini L, Esprit A, Gelpí JL, Martínez-Jiménez F, López-Bigas N, Breckpot K, Thielemans K, Leal L, Gómez CE, Sisteré-Oró M, Meyerhans A, Esteban M, Alonso MJ, García F, Plana M; COVARNA Consortium.
Esteban I, et al. Among authors: usero l.
Vaccines (Basel). 2023 Dec 22;12(1):15. doi: 10.3390/vaccines12010015.
Vaccines (Basel). 2023.
PMID: 38250827
Free PMC article.